Antioxidant Properties of Mesalamine in Colitis Inhibit Phosphoinositide 3-Kinase Signaling in Progenitor Cells

Mesalazine inhibits theβ-catenin signalling pathway acting through the upregulation of μ-protocadherin gene in colo-rectal cancer cells

(2009) S. PARENTI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Mesalamine Protects Against Colorectal Cancer in Inflammatory Bowel Disease

(2009) Jeffrey Tang et al.   DIGESTIVE DISEASES AND SCIENCES

Mesalamine Inhibits Epithelial β-Catenin Activation in Chronic Ulcerative Colitis

(2009) Jeffrey B. Brown et al.   GASTROENTEROLOGY

Association of reactive oxygen species levels and radioresistance in cancer stem cells

(2009) Maximilian Diehn et al.   NATURE

PPAR  is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cells

(2008) M. Schwab et al.   CARCINOGENESIS

Inhibition of cell proliferation and invasion in a human colon cancer cell line by 5-aminosalicylic acid

(2008) Y.-H. Kim et al.   DIGESTIVE AND LIVER DISEASE

Rosiglitazone for Active Ulcerative Colitis: A Randomized Placebo-Controlled Trial

(2008) James D. Lewis et al.   GASTROENTEROLOGY

Peroxisome Proliferator-Activated Receptor γ (PPARγ) Suppresses Colonic Epithelial Cell Turnover and Colon Carcinogenesis Through Inhibition of the β-Catenin / T Cell Factor (TCF) Pathway

(2008) Toshio Fujisawa et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Crypt stem cells as the cells-of-origin of intestinal cancer

(2008) Nick Barker et al.   NATURE

A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitis

(2008) Hong-Liang Liang et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid

(2007) Carmine Stolfi et al.   BIOCHEMICAL PHARMACOLOGY

Epithelial: Lamina Propria Lymphocyte Interactions Promote Epithelial Cell Differentiation

(2007) Stephanie Dahan et al.   GASTROENTEROLOGY

Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine

(2007) Sreedhar Subramanian et al.   INFLAMMATORY BOWEL DISEASES